BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30293248)

  • 1. Contribution of next generation sequencing in pediatric practice in Lebanon. A Study on 213 cases.
    Nair P; Sabbagh S; Mansour H; Fawaz A; Hmaimess G; Noun P; Dagher R; Megarbane H; Hana S; Alame S; Lamaa M; Hasbini D; Farah R; Rajab M; Stora S; El-Tourjuman O; Abou Jaoude P; Chalouhi G; Sayad R; Gillart AC; Al-Ali M; Delague V; El-Hayek S; Mégarbané A
    Mol Genet Genomic Med; 2018 Nov; 6(6):1041-1052. PubMed ID: 30293248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes.
    Monies D; Abouelhoda M; AlSayed M; Alhassnan Z; Alotaibi M; Kayyali H; Al-Owain M; Shah A; Rahbeeni Z; Al-Muhaizea MA; Alzaidan HI; Cupler E; Bohlega S; Faqeih E; Faden M; Alyounes B; Jaroudi D; Goljan E; Elbardisy H; Akilan A; Albar R; Aldhalaan H; Gulab S; Chedrawi A; Al Saud BK; Kurdi W; Makhseed N; Alqasim T; El Khashab HY; Al-Mousa H; Alhashem A; Kanaan I; Algoufi T; Alsaleem K; Basha TA; Al-Murshedi F; Khan S; Al-Kindy A; Alnemer M; Al-Hajjar S; Alyamani S; Aldhekri H; Al-Mehaidib A; Arnaout R; Dabbagh O; Shagrani M; Broering D; Tulbah M; Alqassmi A; Almugbel M; AlQuaiz M; Alsaman A; Al-Thihli K; Sulaiman RA; Al-Dekhail W; Alsaegh A; Bashiri FA; Qari A; Alhomadi S; Alkuraya H; Alsebayel M; Hamad MH; Szonyi L; Abaalkhail F; Al-Mayouf SM; Almojalli H; Alqadi KS; Elsiesy H; Shuaib TM; Seidahmed MZ; Abosoudah I; Akleh H; AlGhonaium A; Alkharfy TM; Al Mutairi F; Eyaid W; Alshanbary A; Sheikh FR; Alsohaibani FI; Alsonbul A; Al Tala S; Balkhy S; Bassiouni R; Alenizi AS; Hussein MH; Hassan S; Khalil M; Tabarki B; Alshahwan S; Oshi A; Sabr Y; Alsaadoun S; Salih MA; Mohamed S; Sultana H; Tamim A; El-Haj M; Alshahrani S; Bubshait DK; Alfadhel M; Faquih T; El-Kalioby M; Subhani S; Shah Z; Moghrabi N; Meyer BF; Alkuraya FS
    Hum Genet; 2017 Aug; 136(8):921-939. PubMed ID: 28600779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The added value of WES reanalysis in the field of genetic diagnosis: lessons learned from 200 exomes in the Lebanese population.
    Jalkh N; Corbani S; Haidar Z; Hamdan N; Farah E; Abou Ghoch J; Ghosn R; Salem N; Fawaz A; Djambas Khayat C; Rajab M; Mourani C; Moukarzel A; Rassi S; Gerbaka B; Mansour H; Baassiri M; Dagher R; Breich D; Mégarbané A; Desvignes JP; Delague V; Mehawej C; Chouery E
    BMC Med Genomics; 2019 Jan; 12(1):11. PubMed ID: 30665423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
    Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
    Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of Early Next-Generation Sequencing for Inborn Errors of Immunity: A Prospective Observational Cohort Study of Diagnostic Yield and Clinical Implications in Dutch Genome Diagnostic Centers.
    Elsink K; Huibers MMH; Hollink IHIM; Simons A; Zonneveld-Huijssoon E; van der Veken LT; Leavis HL; Henriet SSV; van Deuren M; van de Veerdonk FL; Potjewijd J; Berghuis D; Dalm VASH; Vermont CL; van de Ven AAJM; Lambeck AJA; Abbott KM; van Hagen PM; de Bree GJ; Kuijpers TW; Frederix GWJ; van Gijn ME; van Montfrans JM;
    Front Immunol; 2021; 12():780134. PubMed ID: 34992599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
    Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
    BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome sequencing in mostly consanguineous Arab families with neurologic disease provides a high potential molecular diagnosis rate.
    Charng WL; Karaca E; Coban Akdemir Z; Gambin T; Atik MM; Gu S; Posey JE; Jhangiani SN; Muzny DM; Doddapaneni H; Hu J; Boerwinkle E; Gibbs RA; Rosenfeld JA; Cui H; Xia F; Manickam K; Yang Y; Faqeih EA; Al Asmari A; Saleh MA; El-Hattab AW; Lupski JR
    BMC Med Genomics; 2016 Jul; 9(1):42. PubMed ID: 27435318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Testing in Egyptian Patients with Inborn Errors of Immunity: a Single-Center Experience.
    El Hawary RE; Meshaal SS; Abd Elaziz DS; Alkady R; Lotfy S; Eldash A; Erfan A; Chohayeb EA; Saad MM; Darwish RK; Boutros JA; Galal NM; Elmarsafy AM
    J Clin Immunol; 2022 Jul; 42(5):1051-1070. PubMed ID: 35482138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of whole-exome sequencing and copy number variation sequencing enables the diagnosis of rare neurological disorders.
    Jiao Q; Sun H; Zhang H; Wang R; Li S; Sun D; Yang XA; Jin Y
    Clin Genet; 2019 Aug; 96(2):140-150. PubMed ID: 30945278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.
    Oberg JA; Glade Bender JL; Sulis ML; Pendrick D; Sireci AN; Hsiao SJ; Turk AT; Dela Cruz FS; Hibshoosh H; Remotti H; Zylber RJ; Pang J; Diolaiti D; Koval C; Andrews SJ; Garvin JH; Yamashiro DJ; Chung WK; Emerson SG; Nagy PL; Mansukhani MM; Kung AL
    Genome Med; 2016 Dec; 8(1):133. PubMed ID: 28007021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic exome sequencing to elucidate the genetic basis of likely recessive disorders in consanguineous families.
    Makrythanasis P; Nelis M; Santoni FA; Guipponi M; Vannier A; Béna F; Gimelli S; Stathaki E; Temtamy S; Mégarbané A; Masri A; Aglan MS; Zaki MS; Bottani A; Fokstuen S; Gwanmesia L; Aliferis K; Bustamante Eduardo M; Stamoulis G; Psoni S; Kitsiou-Tzeli S; Fryssira H; Kanavakis E; Al-Allawi N; Sefiani A; Al Hait S; Elalaoui SC; Jalkh N; Al-Gazali L; Al-Jasmi F; Bouhamed HC; Abdalla E; Cooper DN; Hamamy H; Antonarakis SE
    Hum Mutat; 2014 Oct; 35(10):1203-10. PubMed ID: 25044680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semiconductor Whole Exome Sequencing for the Identification of Genetic Variants in Colombian Patients Clinically Diagnosed with Long QT Syndrome.
    Burgos M; Arenas A; Cabrera R
    Mol Diagn Ther; 2016 Aug; 20(4):353-62. PubMed ID: 27251404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnostic testing for congenital disorders of glycosylation (CDG): detection rate for single gene testing and next generation sequencing panel testing.
    Jones MA; Rhodenizer D; da Silva C; Huff IJ; Keong L; Bean LJ; Coffee B; Collins C; Tanner AK; He M; Hegde MR
    Mol Genet Metab; 2013; 110(1-2):78-85. PubMed ID: 23806237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole Exome Sequencing Is the Preferred Strategy to Identify the Genetic Defect in Patients With a Probable or Possible Mitochondrial Cause.
    Theunissen TEJ; Nguyen M; Kamps R; Hendrickx AT; Sallevelt SCEH; Gottschalk RWH; Calis CM; Stassen APM; de Koning B; Mulder-Den Hartog ENM; Schoonderwoerd K; Fuchs SA; Hilhorst-Hofstee Y; de Visser M; Vanoevelen J; Szklarczyk R; Gerards M; de Coo IFM; Hellebrekers DMEI; Smeets HJM
    Front Genet; 2018; 9():400. PubMed ID: 30369941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of next-generation sequencing technologies in diagnosis of Mendelian mitochondrial diseases and reflections on clinical spectrum.
    Kose M; Isik E; Aykut A; Durmaz A; Kose E; Ersoy M; Diniz G; Adebali O; Ünalp A; Yilmaz Ü; Karaoğlu P; Edizer S; Tekin HG; Özdemir TR; Atik T; Onay H; Özkınay F
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):417-430. PubMed ID: 33629572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility in infants with suspected monogenic conditions through next-generation sequencing.
    Hong S; Wang L; Zhao D; Zhang Y; Chen Y; Tan J; Liang L; Zhu T
    Mol Genet Genomic Med; 2019 Jun; 7(6):e684. PubMed ID: 30968598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic yield of next-generation sequencing applied to neurological disorders.
    Marques Matos C; Alonso I; Leão M
    J Clin Neurosci; 2019 Sep; 67():14-18. PubMed ID: 31272831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
    Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
    Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.